Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
EIK1001, Pembrolizumab, and Chemotherapy for Stage 4 Non-Small Cell Lung Cancer in Patients with Stage 4 Non-Small Cell Lung Cancer
Recruiting
Investigated Diseases:Investigated Drugs:
+6A study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors
Recruiting
Investigated Diseases:Investigated Drugs: 
A study of PF-08634404 and a drug combination in adults with advanced or metastatic non-small cell lung cancer
Recruiting
Investigated Diseases:Investigated Drugs:
+2A study of mRNA-4157 and a drug combination for patients with stage IV non-small cell lung cancer
Recruiting
Investigated Drugs: 
A study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer
Recruiting
Investigated Diseases:Investigated Drugs: A study testing BNT326 and BNT327 with drug combination for safety and effectiveness in people with advanced non-small cell lung cancer
Recruiting
Investigated Diseases:Investigated Drugs: A Study of Amivantamab and Lazertinib for Adults with EGFR-Mutated Advanced or Metastatic Non-Small Cell Lung Cancer
Recruiting
Investigated Drugs: 
+3A Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment
Recruiting
Investigated Diseases:Investigated Drugs: 
+9Study of THIO and cemiplimab compared to chemotherapy in patients with advanced non-small cell lung cancer who have received two previous treatments
Recruiting
Investigated Diseases:Investigated Drugs: 
